AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lucid Diagnostics Inc. Director's Dealing 2023

Sep 22, 2023

33983_dirs_2023-09-22_6765ba6c-b6c9-45a6-a45a-1bb5acf65acd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2023-09-20

Reporting Person: Lapidus Stanley (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-20	Common stock	S	3405	$1.45	Disposed	132051	Direct
2023-09-20	Common stock	S	412	$1.44	Disposed	131639	Direct
2023-09-21	Common stock	S	100	$1.44	Disposed	131539	Direct

Footnotes

F1: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.

F2: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.